HILLSTREAM BIOPHARMA
Hillstream BioPharma is a development-stage company advancing improved therapies for patients with cancer via a unique QUATRAMERTM nanoparticle platform. This unique technology enables intranuclear and intracellular delivery of small molecules, peptides, genes, other macromolecules and biologics to the tumor cello, while significantly minimizing exposure to normal tissues. Hillstreamโs competitive advantage is to enhance the safety and efficacy of oncology therapies by encapsulating them in its proprietary polymeric injectable suspension comprised of FDA-recognized inactive ingredients.
HILLSTREAM BIOPHARMA
Industry:
Biopharma
Address:
Chester, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.hillstreambio.com
Status:
Active
Contact:
+1 302.743.2995
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Current Employees Featured
Founder
Official Site Inspections
http://www.hillstreambio.com Semrush global rank: 4.04 M Semrush visits lastest month: 3.04 K
- Host name: 217.21.76.42
- IP address: 217.21.76.42
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Hillstream BioPharma"
About - Tharimmune, Inc.
Sireesh Appajosyula has served as a member of our board of directors since July 2021. Since April 2020, he has served as SVP, Corporate Development and Operations of 9 Meters โฆSee details»
Tharimmune - Crunchbase Company Profile & Funding
Organization. Tharimmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Tharimmune is a development-stage company โฆSee details»
Hillstream BioPharma Progressing Towards Acquiring Clinical โฆ
Sep 22, 2023 The corporate name change is based on the Greek word โthárrosโ, translated to mean courage and reflects the transformation of the Company into a patient-focused, clinical โฆSee details»
Hillstream Biopharma - Overview, News & Similar companies
May 14, 2023 Hillstream Biopharma contact info: Phone number: (908) 955-3140 Website: www.hillstreambio.com What does Hillstream Biopharma do? Hillstream BioPharma is a โฆSee details»
Hillstream BioPharma Strengthens its Board of Directors with ...
May 15, 2023 The erbB/HER family of cell surface proteins include well-known and validated drug targets including HER2 and HER3 found in multiple solid tumors, including breast, lung, โฆSee details»
Hillstream BioPharma Licenses Technology to Develop
Jul 6, 2023 The Applied Biomedical Science Institute (ABSI) is a 501(c)(3) non-profit organization taking a leading role in basic research and its rapid clinical translation by โฆSee details»
Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical โฆ
Apr 13, 2023 OncoBay Clinical is a boutique clinical research organization (CRO) that is a subsidiary of the Moffitt Cancer Center and has extensive experience in oncology drug โฆSee details»
Hillstream BioPharma Selects OncoBay Clinical to Advance
Apr 13, 2023 OncoBay Clinical is a boutique clinical research organization (CRO) that is a subsidiary of the Moffitt Cancer Center and has extensive experience in oncology drug โฆSee details»
Hillstream BioPharma Announces Development of Proprietary
Dec 1, 2022 For more information, please visit: www.hillstreambio.com. About Minotaur Therapeutics Minotaur Therapeutics is a private biotechnology company developing unique โฆSee details»
Hillstream BioPharma Announces Collaboration with Ardena to โฆ
Nov 4, 2019 For more information, please visit hillstreambio.com. About Ardena Ardena is a fully integrated Contract Development and Manufacturing Organization with a core focus on โฆSee details»
Hillstream BioPharma, Inc. to Present at Upcoming Investor โฆ
Archived Recording: ir.hillstreambio.com Time: Please check with the conference coordinator as presentation times are subject to change. Location: The Mandarin Oriental Hotel in New York โฆSee details»
Hillstream Enters into an Exclusive Option Agreement to Acquire a ...
Sep 11, 2023 Embedded onto a proprietary transdermal buccal film which easily adheres to the inside of the mouth, AV104โs key features make it an ideal product candidate for multiple liver โฆSee details»
Hillstream BioPharma Signs Exclusive Option Agreement with
Feb 13, 2023 The Applied Biomedical Science Institute (ABSI) is a 501(c)(3) non-profit organization taking a leading role in basic research and its rapid clinical translation by โฆSee details»
Hillstream BioPharma Announces Acceptance of Abstract at AACR โฆ
Feb 8, 2023 About HSB-510 HSB-510 is a novel highly targeted bifunctional inhibitor encapsulated in Quatramer with single digit nanomolar IC 50 against PI3-Kฮด and HDAC6, โฆSee details»
Hillstream BioPharma Acquires Key Assets to Portfolio Including ...
Sep 10, 2019 For more information, please visit hillstreambio.com. Hillstream BioPharma Inc. Randy Milby President & CEO Hillstream Biopharma Inc. Tel: +1 302.743.2995See details»
Hillstream BioPharma Selects OncoBay Clinical to Advance
Apr 13, 2023 OncoBay Clinical is a global boutique contract research organization (CRO) specializing in immuno- oncology/cell therapy and other complex oncology programs. ... For โฆSee details»
Top Edgar Filing Services In US | M2 Compliance
It was a pleasure working with your organization. I liked the attention to detail and you guys practice that. I look forward to working with you guys. Few press releases, the Proxy and Q1 โฆSee details»
Hillstream BioPharma Licenses Technology to Develop Proprietary โฆ
Jul 6, 2023 The Applied Biomedical Science Institute (ABSI) is a 501(c)(3) non-profit organization taking a leading role in basic research and its rapid clinical translation by โฆSee details»
Hillstream BioPharma Signs Exclusive Option Agreement with โฆ
Feb 13, 2023 HER2 and HER3 Conformational Domain Bridging Epitopes in Antibodies via an Exclusive Option Allows Hillstream BioPharma to Develop Proprietary Multi-format Biologics โฆSee details»
Hillstream BioPharma Provides Business Review with Key Pipeline โฆ
Jan 14, 2022 Continued development and validation of HSB-1216 as a leading Ferroptosis inducer to enter the clinic Successful Closing of a $15 million Initial Public Offering on January โฆSee details»